Proteome profiling of early gestational plasma reveals novel biomarkers of congenital heart disease

Proteome profiling of early gestational plasma reveals novel biomarkers of congenital heart disease

Abstract Prenatal diagnosis of congenital heart disease (CHD) relies primarily on fetal echocardiography conducted at mid‐gestational age—the sensitivity of which varies among centers and practitioners. An objective method for early diagnosis is needed. Here, we conducted a case–control study recrui...

Full description

Bibliographic Details
Main Authors: Ya‐Nan Yin, Li Cao, Jie Wang, Yu‐Ling Chen, Hai‐Ou Yang, Su‐Bei Tan, Ke Cai, Zhe‐Qi Chen, Jie Xiang, Yuan‐Xin Yang, Hao‐Ran Geng, Ze‐Yu Zhou, An‐Na Shen, Xiang‐Yu Zhou, Yan Shi, Rui Zhao, Kun Sun, Chen Ding, Jian‐Yuan Zhao
Format: Article
Language:English
Published: Springer Nature 2023-12-01
Series:EMBO Molecular Medicine
Subjects:
congenital heart disease
plasma
proteomics gestational
Online Access:https://doi.org/10.15252/emmm.202317745

Internet

https://doi.org/10.15252/emmm.202317745

Similar Items